Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 92,448,158
- Total 13F shares
- 11,327,999
- Share change
- +2,434,240
- Total reported value
- $21,748,342
- Put/Call ratio
- 107%
- Price per share
- $1.92
- Number of holders
- 51
- Value change
- +$3,203,973
- Number of buys
- 31
- Number of sells
- 29
Quarterly Holders Quick Answers
What is CUSIP 92511W108?
CUSIP 92511W108 identifies VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92511W108:
Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.9%
|
3,610,412
|
$29,280,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.85%
|
781,712
|
$6,339,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.84%
|
779,820
|
$6,324,000 | — | 31 Mar 2022 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.77%
|
708,976
|
$5,750,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.75%
|
692,159
|
$5,614,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
0.7%
|
645,550
|
$5,235,000 | — | 31 Mar 2022 | |
| Fosun International Ltd |
13F
|
Company |
0.31%
|
282,408
|
$2,290,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
231,035
|
$1,874,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
217,398
|
$1,763,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
135,956
|
$1,103,000 | — | 31 Mar 2022 | |
| SteelPeak Wealth, LLC |
13F
|
Company |
0.14%
|
133,411
|
$1,082,000 | — | 31 Mar 2022 | |
| Altium Capital Management LLC |
13F
|
Company |
0.11%
|
97,887
|
$794,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.11%
|
97,707
|
$792,000 | — | 31 Mar 2022 | |
| MML INVESTORS SERVICES, LLC |
13F
|
Company |
0.07%
|
60,500
|
$491,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
55,889
|
$454,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
45,807
|
$372,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.04%
|
32,788
|
$277,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
33,450
|
$272,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.04%
|
32,817
|
$266,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
29,640
|
$240,000 | — | 31 Mar 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
24,550
|
$199,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
19,758
|
$160,000 | — | 31 Mar 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
19,100
|
$155,000 | — | 31 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
12,769
|
$104,000 | — | 31 Mar 2022 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
0.01%
|
11,298
|
$92,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
10,802
|
$88,000 | — | 31 Mar 2022 | |
| A. Brian Davis |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
12,900
|
$83,721 | — | 04 Jun 2021 | |
| BECK MACK & OLIVER LLC |
13F
|
Company |
0.01%
|
10,000
|
$81,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
9,367
|
$76,000 | — | 31 Mar 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
8,235
|
$67,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
7,323
|
$60,000 | — | 31 Mar 2022 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
6,502
|
$53,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
5,985
|
$48,000 | — | 31 Mar 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
5,520
|
$45,000 | — | 31 Mar 2022 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.01%
|
5,111
|
$41,000 | — | 31 Mar 2022 | |
| Spire Wealth Management |
13F
|
Company |
0%
|
3,827
|
$31,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
3,196
|
$26,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,810
|
$23,000 | — | 31 Mar 2022 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
2,133
|
$17,000 | — | 31 Mar 2022 | |
| Amalgamated Financial Corp. |
13F
|
Company |
0%
|
2,133
|
$17,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
2,125
|
$17,000 | — | 31 Mar 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,437
|
$12,000 | — | 31 Mar 2022 | |
| Asset Dedication, LLC |
13F
|
Company |
0%
|
1,193
|
$10,000 | — | 31 Mar 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,201
|
$9,740 | — | 31 Mar 2022 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
1,080
|
$9,000 | — | 31 Mar 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,061
|
$9,000 | — | 31 Mar 2022 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
427
|
$3,000 | — | 31 Mar 2022 | |
| STRS OHIO |
13F
|
Company |
0%
|
300
|
$2,000 | — | 31 Mar 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
200
|
$2,000 | — | 31 Mar 2022 |
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2022
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.